ArticleJournal of chromatographic science2026
A Rapid and Validated Reversed-Phase High-Performance Liquid Chromatographic Method with Pre-Column Derivatization and Fluorescence Detection for Quantification of Twenty Amino Acids in Total Parenteral Nutrition Solutions.
Article in Journal of chromatographic science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate quantification of all 20 proteinogenic amino acids (AAs) is critical for the quality control of total parenteral nutrition (TPN) formulations containing complex excipient matrices. This study presents a rapid and validated reversed-phase high-performance liquid chromatography (RP-HPLC) method employing pre-column derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) and fluorescence detection (FLD) for the simultaneous determination of AAs. Complete baseline separation of all 20 AAs was achieved within 18 minutes, with a total analytical run time of 25 minutes on a conventional HPLC system. The method was validated in accordance with ICH Q2(R2) guidelines, demonstrating excellent linearity (R2 > 0.999), high sensitivity (limits of detection = 0.02-0.16 μmol/L), precision (relative standard deviation< 2%), accuracy (recoveries = 98.2-101.7%), specificity (no matrix interference) and robustness under deliberate minor variations in chromatographic conditions. These findings confirm the method's reliability and suitability for pharmaceutical quality control. This RP-HPLC-FLD method provides a rapid, cost-effective and reproducible alternative to LC-MS for routine quality control of TPN formulations in pharmaceutical laboratories.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.